Table 2.
Percent of participants who use each variable or test for selection and/or monitoring during active surveillance (n = 23).
| # (%) Using for selection | # (%) Using for monitoring | |
|---|---|---|
| Age | 13 (56.5) | 11 (47.8) |
| PSA or PSA derivative | 21 (91.3) | 22 (95.7) |
| Clinical stage | 21 (91.3) | 19 (82.6) |
| Grade | 23 (100) | 21 (91.3) |
| Other biopsy features | 19 (82.6) | 15 (65.2) |
| Imaging | 14 (60.9) | 12 (52.2) |
| Other test | 8 (34.8) | 4 (17.4) |